Ether

Ether

SCHEMBL355997

CCCCCCCCCCCCCCOS(=O)(=O)[O-].CCOCC.[Na+]

nearest known ligand 0.85

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Ether. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 known ✓ P00915 10/20 0.52
CA2 known ✓ P00918 10/20 0.52
CA12 known ✓ O43570 3/20 0.52
CA4 known ✓ P22748 2/20 0.52
FGF1 known ✓ P05230 3/20 0.39
RECQL P46063 2/20 0.85
TSHR P16473 2/20 0.85
GLA P06280 1/20 0.85
HPGD P15428 1/20 0.85
MAPK1 P28482 1/20 0.85
EPHX2 P34913 1/20 0.85
BLM P54132 1/20 0.85
CA9 Q16790 8/20 0.52
CA7 P43166 3/20 0.52
CA14 Q9ULX7 3/20 0.52
CA3 P07451 2/20 0.52
CA6 P23280 2/20 0.52
CA5A P35218 2/20 0.52
CA5B Q9Y2D0 2/20 0.52
CES2 O00748 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL11756362 1.00 RECQL (0.85) RECQLTSHRGLAHPGDMAPK1
Ether SCHEMBL1978126 1.00 RECQL (0.85) RECQLTSHRGLAHPGDMAPK1
Ether SCHEMBL7537883 1.00 RECQL (0.85) RECQLTSHRGLAHPGDMAPK1
Ether SCHEMBL15283 1.00 RECQL (0.85) RECQLTSHRGLAHPGDMAPK1
Ether SCHEMBL7537830 1.00 RECQL (0.85) RECQLTSHRGLAHPGDMAPK1
Ether SCHEMBL23674209 1.00 RECQL (0.85) RECQLTSHRGLAHPGDMAPK1
Octadecyl Sulfate SCHEMBL9771950 1.00 RECQL (0.85) RECQLTSHRGLAHPGDMAPK1
Ether SCHEMBL11022896 1.00 RECQL (0.85) RECQLTSHRGLAHPGDMAPK1
Ether SCHEMBL21641350 1.00 RECQL (0.85) RECQLTSHRGLAHPGDMAPK1
Ether SCHEMBL324781 1.00 RECQL (0.85) RECQLTSHRGLAHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 452 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4734945-A1 WASH COMPOSITION WITH ANIONIC SULFATE AND SULTAINE NOT RELIANT ON PALM KERNEL OIL Unilever IP Holdings B.V. (NL) 2026-05-06 EP claimed
WO-2025002874-A1 WASH COMPOSITION WITH ANIONIC SULFATE AND SULTAINE NOT RELIANT ON PALM KERNEL OIL UNILEVER IP HOLDINGS B.V. (NL) 2025-01-02 WO claimed
CN-114349143-B Complex coacervate phase system and preparation method and application thereof 扬州大学 2023-04-14 CN claimed
CN-110068692-B Unmasking endotoxins in solution 海格罗斯投资有限责任公司 2023-04-14 CN claimed
EP-3767289-B1 TEST DEVICE AND METHOD FOR SEMI-QUANTITATIVE DETERMINATION OF CHLORINE DIOXIDE IN A LIQUID SAMPLE CONTAINING FREE CHLORINE AXAGARIUS GMBH & CO KG (DE) 2022-08-31 EP claimed
US-11371973-B2 Test device and method for the semi-quantitative determination of chlorine dioxide in a liquid sample containing free chlorine AXAGARIUS GMBH & CO. KG (DE) 2022-06-28 US claimed
CN-114514052-A Phosphorus nitrogen substitute for PFC foam 罗伯特·瓦伦丁·卡索斯基 2022-05-17 CN claimed
CN-114349143-A Complex coacervate phase system and preparation method and application thereof 扬州大学 2022-04-15 CN claimed
CN-111134122-B Efficient spreading agent for promoting water drops to impact on super-hydrophobic surface and completely spread 中国科学院化学研究所 2021-07-27 CN claimed
US-20210018478-A1 TEST DEVICE AND METHOD FOR THE SEMI-QUANTITATIVE DETERMINATION OF CHLORINE DIOXIDE IN A LIQUID SAMPLE CONTAINING FREE CHLORINE AXAGARIUS GMBH & CO. KG (DE) 2021-01-21 US claimed
US-20080081771-A1 Aqueous well bore fracturing fluid containing gas component, thickener and such as fatty alcohol ethoxylated sodium sulfate anionic surfactant; low cost; viscosity and foam stability SCHLUMBERGER TECHNOLOGY CORPORATION 2008-04-03 US claimed
US-20060039882-A1 Hair care agents containing pregelatinized, cross-linked starch derivatives BEIERSDORF AG (DE) 2006-02-23 US claimed
US-20050112157-A1 Foaming cleansing emulsions containing starch BEIERSDORF AG. 2005-05-26 US claimed
EP-1058532-B1 HIGH ALKALINE HAIR COMPOSITIONS FOR INCREASED FULLNESS AND BODY P & G CLAIROL INC (US) 2004-11-24 EP claimed
US-6348439-B1 SHAMPOO, RINSES, AND HAIR CONDITIONERS ADD FULLNESS OR FLUFFINESS TO FINE HAIR; NONIONIC SURFACTANT OF POLYOXYETHYLENE GLYCOL AND ANIONIC SURFACTANT IN WATER; STORAGE STABILITY BRISTOL-MYERS SQUIBB COMPANY 2002-02-19 US claimed
EP-0788787-B1 Oxidation hair dye composition based upon a gel carrier WELLA AG (DE) 2001-09-19 EP claimed
CN-1291882-A High alkaline hair compositions for increased fullness and body BRISTOL MYERS SQUIBB CO (US) 2001-04-18 CN claimed
EP-1058532-A1 HIGH ALKALINE HAIR COMPOSITIONS FOR INCREASED FULLNESS AND BODY Bristol-Myers Squibb Company (US) 2000-12-13 EP claimed
US-6010990-A CATIONIC POLYMER, ANIONIC SURFACTANT, PH OF 8-10 BRISTOL-MYERS SQUIBB COMPANY (US) 2000-01-04 US claimed
WO-1999044568-A1 HIGH ALKALINE HAIR COMPOSITIONS FOR INCREASED FULLNESS AND BODY BRISTOL-MYERS SQUIBB COMPANY (US) 1999-09-10 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050112157-A1 Foaming cleansing emulsions containing starch CSTB, SHBG, HBB CA1 4793/4885CA2 4733/4885CA12 4178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.